semaglutide for eating disorder Concerns over Ozempic misuse and risks prompt calls increased screening With GLP-1s readily available, some

who described it to be upregulated in colorectal adenomas and CRC (118)

In a retrospective study completed by Nadeem et al., it was shown that GLP-1 RAs are associated with an overall fourfold increase in the retention of gastric contents in both diabetic and non-diabetic patients ( p -value 0.8 mL/kg of gastric fluid content (measured from the aspiration/suction canister)

It can also inhibit the production of glucagon by pancreatic -cells when blood glucose levels are high

Type 1 diabetes mellitus

It's a thermogenic effect from glucagon activation not a fever, not organ stress

Ozempic (semaglutide) administration (semaglutide) administration Thinnest needle (32G, 4 mm) on a once-weekly GLP-1 RA included with each pen 1 1 Red Label Pen that delivers doses of 0.25 mg and 0.5 mg Contains 2 mg of Ozempic Delivers only the starting dose of 0.25 mg and a maintenance dose of 0.5 mg Blue Label Pen that delivers doses of 1 mg Contains 4 mg of Ozempic Delivers only the maintenance dose of 1 mg Yellow Label Pen that delivers doses of 2 mg Contains 8 mg of Ozempic Delivers only the maximum maintenance dose of 2 mg Steps to deliver your dose 1 1 No matter if a patient is initiating, maintaining, or escalating their Ozempic pen dose, inform them to follow these steps for proper administration